Litcius/Paper detail

An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial

Katrina M. Pollock, Álvaro H. Borges, Hannah M. Cheeseman, Ida Rosenkrands, Kirstine L Schmidt, Rie E Søndergaard, Suzanne Day, Abbey Evans, Leon R. McFarlane, Jennifer Joypooranachandran, Fahimah Amini, Per Skallerup, Rebecca Bach Dohn, Charlotte G Jensen, Anja Weinreich Olsen, Peter Fibiger Bang, Tom Cole, J Schronce, Nana‐Marie Lemm, Max P Kristiansen, Peter Andersen, Jes Dietrich, Robin J. Shattock, Frank Follmann

2024The Lancet Infectious Diseases38 citationsDOIOpen Access PDF

Topics & Concepts

TrachomaChlamydiaMedicineDouble blindChlamydia trachomatisCationic liposomePhase (matter)VirologyImmunologyAlternative medicineBiologyChemistryPathologyPlaceboGeneOrganic chemistryBiochemistryGenetic enhancementReproductive tract infections researchCervical Cancer and HPV ResearchPreterm Birth and Chorioamnionitis